Dunn J T
Department of Medicine, University of Virginia Health Sciences Center, Charlottesville, 22908, USA.
J Clin Endocrinol Metab. 1996 Apr;81(4):1332-5. doi: 10.1210/jcem.81.4.8636328.
Iodine deficiency is a problem for almost all countries of the world. Goiter is its most obvious consequence, but others do more damage, particularly effects on the developing brain. In 1990, most countries and international agencies pledged the virtual elimination of iodine deficiency by the year 2000. The technology for the assessment and implementation is sufficient to attain this goal, but translating its potential into success requires careful planning. This article reviews seven major errors that frequently occur in iodine supplementation programs and offers suggestions for their avoidance. They are 1) unreliable assessment of iodine deficiency: the best indicators are urinary iodine concentration, thyroid size (preferably by ultrasound), blood spot thyroglobulin levels, and neonatal TSH determinations; the best group for surveys is schoolchildren; 2) poor iodine supplementation plan: iodized salt is the preferred supplement; its effective application frequently requires extensive changes in salt production and marketing, and poor handling of these changes will endanger the iodization program; other measures include iodized oil, iodized water, and iodine drops; all are occasionally useful, but the long range solution should generally be iodized salt; 3) exclusion of relevant stake-holders: the program should include not only health authorities but other arms of the government as well (education, commerce, agriculture, and standards), the salt industry, health professionals, and the iodine-deficient community itself; 4) inadequate education: an understanding of the effects of iodine deficiency and the means for its correction is essential at all levels, from government to affected population; 5) insufficient monitoring: the best instruments are urinary iodine levels, iodized salt use, and thyroid size, measured in representative groups at regular intervals with public reporting of results; 6) inattention to cost: the expense of iodization must be recognized and apportioned fairly; and 7) nonsustainability: for permanent success, an iodization program must be fair to all relevant parties and accompanied by a regular system of appropriate monitoring. Only with careful avoidance of these seven "deadly sins" can the goal of sustainable elimination of iodine deficiency be achieved.
碘缺乏是世界上几乎所有国家都面临的问题。甲状腺肿是其最明显的后果,但其他影响危害更大,尤其是对发育中大脑的影响。1990年,大多数国家和国际机构承诺到2000年基本消除碘缺乏。评估和实施的技术足以实现这一目标,但要将其潜力转化为成功则需要精心规划。本文回顾了碘补充计划中经常出现的七个主要错误,并提出了避免这些错误的建议。它们分别是:1)碘缺乏评估不可靠:最佳指标是尿碘浓度、甲状腺大小(最好通过超声测量)、血斑甲状腺球蛋白水平和新生儿促甲状腺激素测定;调查的最佳群体是学童;2)碘补充计划不完善:加碘盐是首选的补充剂;其有效应用通常需要对盐的生产和销售进行广泛变革,而对这些变革处理不当会危及碘化计划;其他措施包括碘油、碘水和碘滴剂;所有这些措施偶尔有用,但长期解决方案一般应为加碘盐;3)排除相关利益攸关方:该计划不仅应包括卫生当局,还应包括政府的其他部门(教育、商业、农业和标准部门)、盐业、卫生专业人员以及碘缺乏社区本身;4)教育不足:从政府到受影响人群的各级都必须了解碘缺乏的影响及其纠正方法;5)监测不足:最佳手段是定期测量代表群体的尿碘水平、加碘盐使用情况和甲状腺大小,并公开报告结果;6)对成本关注不够:必须认识到碘化的费用并公平分摊;7)不可持续性:为了取得持久成功,碘化计划必须对所有相关方公平,并伴有定期的适当监测系统。只有谨慎避免这七宗“致命罪过”,才能实现可持续消除碘缺乏的目标。